Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Non-cash Items (2018 - 2025)

TransMedics (TMDX) has 8 years of Non-cash Items data on record, last reported at $199.7 million in Q4 2025.

  • For Q4 2025, Non-cash Items rose 159.84% year-over-year to $199.7 million; the TTM value through Dec 2025 reached $199.7 million, up 159.84%, while the annual FY2025 figure was $199.7 million, 159.84% up from the prior year.
  • Non-cash Items reached $199.7 million in Q4 2025 per TMDX's latest filing, up from $76.9 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $199.7 million in Q4 2025 and bottomed at $14.6 million in Q4 2021.
  • Average Non-cash Items over 5 years is $116.5 million, with a median of $132.1 million recorded in 2022.
  • Peak YoY movement for Non-cash Items: soared 803.08% in 2022, then crashed 51.77% in 2024.
  • A 5-year view of Non-cash Items shows it stood at $14.6 million in 2021, then skyrocketed by 803.08% to $132.1 million in 2022, then increased by 20.64% to $159.3 million in 2023, then plummeted by 51.77% to $76.9 million in 2024, then surged by 159.84% to $199.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $199.7 million in Q4 2025, $76.9 million in Q4 2024, and $159.3 million in Q4 2023.